Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin in Open Abdomen Closure
NCT06556030Phase 4Not yet recruiting
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of botulinum toxin type A in open abdomen (OA), sponsored by Hospital La Paz Institute for Health Research. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
open abdomen (OA)
Beyond the preview
Go deeper on NCT06556030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06556030.